Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

CDTX holding history

Cidara Therapeutics, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CDTX overviewAll 13F holders of CDTXFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of CDTX by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−542,722−100.0%Sold outHolders
Q4 2025542,722$119.9M<0.1%+164,538+43.5%AddedHolders
Q3 2025378,184$36.2M<0.1%−505,231−57.2%ReducedHolders
Q2 2025883,415$43.0M<0.1%+875,198+10,651.1%AddedHolders
Q1 20258,217$177.0K<0.1%+5,787+238.1%AddedHolders
Q4 20242,430$65.3K<0.1%+2,261+1,337.9%AddedHolders
Q3 2024169$1.82K<0.1%00.0%UnchangedHolders
Q2 2024169$2.02K<0.1%−611−78.3%ReducedConverted for a 1-for-20 splitHolders
Q1 202415,598$14.3K<0.1%−5,000−24.3%ReducedHolders
Q4 202320,598$16.4K<0.1%−168,000−89.1%ReducedHolders
Q3 2023188,598$177.7K<0.1%−254,500−57.4%ReducedHolders
Q2 2023443,098$500.7K<0.1%+187,598+73.4%AddedHolders
Q1 2023255,500$324.5K<0.1%+254,000+16,933.3%AddedHolders
Q4 20221,500$1.13K<0.1%00.0%UnchangedHolders
Q3 20221,500$1.00K<0.1%00.0%UnchangedHolders
Q2 20221,500$1.00K<0.1%−1,000−40.0%ReducedHolders
Q1 20222,500$2.00K<0.1%+829+49.6%AddedHolders
Q4 20211,671$2.00K<0.1%−5,437−76.5%ReducedHolders
Q3 20217,108$16.0K<0.1%+4,169+141.9%AddedHolders
Q2 20212,939$6.00K<0.1%+1,146+63.9%AddedHolders
Q1 20211,793$5.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.